Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |